🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/08/2018 | 125,58 | 128,38 | 123,05 | 127,01 | +0,67% | 4,24% | 513.200 |
| 08/08/2018 | 124,83 | 128,88 | 123,23 | 126,17 | +1,08% | 4,53% | 1.053.000 |
| 07/08/2018 | 124,51 | 126,27 | 123,00 | 124,82 | +0,86% | 2,63% | 338.700 |
| 06/08/2018 | 126,10 | 129,00 | 122,20 | 123,75 | -2,61% | 5,39% | 390.200 |
| 03/08/2018 | 123,74 | 127,39 | 123,74 | 127,07 | +3,11% | 2,95% | 341.600 |
| 02/08/2018 | 117,79 | 124,74 | 116,90 | 123,24 | +5,64% | 6,66% | 483.900 |
| 01/08/2018 | 122,91 | 124,59 | 113,50 | 116,66 | -5,09% | 9,02% | 603.800 |
| 31/07/2018 | 121,14 | 125,09 | 120,49 | 122,91 | +2,20% | 3,80% | 383.100 |
| 30/07/2018 | 123,17 | 123,73 | 119,07 | 120,26 | -2,21% | 3,78% | 443.600 |
| 27/07/2018 | 125,89 | 125,89 | 121,83 | 122,98 | -2,15% | 3,23% | 325.900 |
| 26/07/2018 | 124,41 | 126,57 | 123,30 | 125,68 | +1,13% | 2,63% | 306.500 |
| 25/07/2018 | 125,18 | 126,17 | 123,69 | 124,27 | -0,39% | 1,98% | 326.800 |
| 24/07/2018 | 127,34 | 127,78 | 124,28 | 124,76 | -0,98% | 2,75% | 279.700 |
| 23/07/2018 | 125,47 | 126,79 | 123,94 | 125,99 | +0,77% | 2,27% | 267.500 |
| 20/07/2018 | 123,46 | 126,64 | 121,82 | 125,03 | +0,76% | 3,90% | 377.700 |
| 19/07/2018 | 123,31 | 124,97 | 121,74 | 124,09 | +0,78% | 2,62% | 242.900 |
| 18/07/2018 | 124,36 | 124,69 | 122,38 | 123,13 | -0,61% | 1,86% | 281.100 |
| 17/07/2018 | 121,50 | 124,04 | 121,47 | 123,89 | +1,35% | 2,12% | 424.300 |
| 16/07/2018 | 124,82 | 124,82 | 121,31 | 122,24 | -2,00% | 2,81% | 408.600 |
| 13/07/2018 | 124,18 | 125,96 | 123,49 | 124,74 | +0,48% | 1,99% | 190.500 |
| 12/07/2018 | 123,52 | 124,18 | 122,40 | 124,14 | +0,94% | 1,44% | 238.100 |
| 11/07/2018 | 120,37 | 123,71 | 120,37 | 122,98 | +1,26% | 2,77% | 276.500 |
| 10/07/2018 | 123,70 | 123,94 | 121,08 | 121,45 | -1,28% | 2,31% | 325.800 |
| 09/07/2018 | 120,49 | 123,60 | 119,98 | 123,03 | +2,28% | 3,00% | 275.700 |
| 06/07/2018 | 117,52 | 120,76 | 115,23 | 120,29 | +2,86% | 4,71% | 321.500 |
| 05/07/2018 | 116,65 | 117,39 | 114,70 | 116,95 | +0,46% | 2,31% | 237.500 |
| 03/07/2018 | 114,64 | 117,71 | 113,84 | 116,41 | +2,28% | 3,38% | 244.200 |
| 02/07/2018 | 111,74 | 114,33 | 110,00 | 113,81 | +0,58% | 3,88% | 296.800 |
| 29/06/2018 | 111,11 | 114,91 | 111,11 | 113,15 | +1,51% | 3,42% | 392.000 |
| 28/06/2018 | 108,85 | 111,62 | 107,08 | 111,47 | +2,78% | 4,17% | 332.400 |